Hunting Hill Global Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Hunting Hill Global Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,596	Closed	-$245K	–	127
2022 Q3	$245K	Buy	+3,596	New	+$198K	0.15%	49

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hunting Hill Global Capital's GBT Position: Q4 2022 in Review

Hunting Hill Global Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,596 shares — an estimated $245K sold.

Hunting Hill Global Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $245K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Hunting Hill Global Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Hunting Hill Global Capital sold 3,596 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $245K.
Hunting Hill Global Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Hunting Hill Global Capital's Global Blood Therapeutics, Inc. position peaked at $245K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Hunting Hill Global Capital's 13F filing for Q4 2022, filed 14 Feb 2023.